(DMAC) Diamedica Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Diamedica Therapeutics | (DMAC) share price targets
Complete technical analysis of Diamedica Therapeutics (DMAC) by charts plus indicators, forecast predictions and share price targets for Diamedica Therapeutics (DMAC)
Diamedica Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-26 View latest technical analysis
10 day averaged volume of Diamedica Therapeutics is 78100
| Date | Daily Closing Price | Open | High | Low | Volume |
| 26 Thu Sep 2024 | 4.30 | 4.15 | 4.31 | 4.15 | 0.419 times |
| 25 Wed Sep 2024 | 4.14 | 4.10 | 4.25 | 4.09 | 0.446 times |
| 24 Tue Sep 2024 | 4.03 | 4.04 | 4.16 | 3.86 | 1.033 times |
| 23 Mon Sep 2024 | 4.01 | 4.10 | 4.18 | 4.01 | 0.675 times |
| 20 Fri Sep 2024 | 4.13 | 4.08 | 4.13 | 4.00 | 2.407 times |
| 19 Thu Sep 2024 | 4.04 | 4.16 | 4.20 | 3.99 | 0.791 times |
| 18 Wed Sep 2024 | 4.13 | 4.36 | 4.48 | 3.98 | 0.987 times |
| 17 Tue Sep 2024 | 4.35 | 4.50 | 4.53 | 4.35 | 0.254 times |
| 16 Mon Sep 2024 | 4.49 | 4.54 | 4.72 | 4.45 | 0.574 times |
| 13 Fri Sep 2024 | 4.50 | 4.34 | 4.95 | 4.23 | 2.417 times |
Share price targets for Diamedica Therapeutics (DMAC)
| Target Type | Value |
| Downside Target | 2.14 |
| Downside Target | 2.50 |
| Downside Target | 2.65 |
| Downside Target | 3.24 |
| Downside Target | 3.73 |
| Downside Target | 3.96 |
| Downside Target | 4.02 |
| Downside Target | 4.07 |
| Upside Target | 4.31 |
| Upside Target | 4.72 |
| Upside Target | 4.95 |
Intraday share price targets for Diamedica Therapeutics (DMAC)
| Target Type | Value |
| Downside Intraday Target | 4 |
| Downside Intraday Target | 3.71 |
| Upside Intraday Target | 4.45 |
| Upside Intraday Target | 4.61 |
| Downside Intraday Target | 4.16 |
Weekly technical analysis of Diamedica Therapeutics (DMAC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 26 Thu Sep 2024 | 4.30 | 4.10 | 4.31 | 3.86 | 0.513 times |
| 20 Fri Sep 2024 | 4.13 | 4.54 | 4.72 | 3.98 | 0.74 times |
| 13 Fri Sep 2024 | 4.50 | 4.07 | 4.95 | 4.02 | 3.379 times |
| 06 Fri Sep 2024 | 4.03 | 4.01 | 4.07 | 3.76 | 10.74 times |
| 30 Fri Aug 2024 | 3.93 | 3.95 | 3.96 | 3.84 | 0.117 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Diamedica Therapeutics (DMAC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 26 Thu Sep 2024 | 4.30 | 4.01 | 4.95 | 3.76 | 1.538 times |
| 30 Fri Aug 2024 | 3.93 | 3.46 | 4.07 | 3.25 | 0.55 times |
| 31 Wed Jul 2024 | 3.28 | 2.95 | 3.81 | 2.65 | 0.868 times |
| 28 Fri Jun 2024 | 2.95 | 2.93 | 3.24 | 2.14 | 2.027 times |
Scroll below to view daily charts
Price has moved up this month, and volume has increased substantially. This means that the move can continue in coming months.
Indicators analysis of Diamedica Therapeutics (DMAC)
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Diamedica Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Diamedica Therapeutics in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Diamedica Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Diamedica Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Diamedica Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.23 and Diamedica Therapeutics (DMAC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Diamedica Therapeutics (DMAC) stock. Volume based technical analysis of Diamedica Therapeutics (DMAC) stock is negative.
Diamedica Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Diamedica Therapeutics stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Diamedica Therapeutics in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Diamedica Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Diamedica Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Diamedica Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.23 and Diamedica Therapeutics (DMAC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Diamedica Therapeutics (DMAC) stock. Volume based technical analysis of Diamedica Therapeutics (DMAC) stock is negative.
Diamedica Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.